Asymptomatic HCM with Significant Left Ventricular Outflow Tract Obstruction

Clinical Scenario

This protocol addresses patients with hypertrophic cardiomyopathy who currently have no symptoms, yet demonstrate a resting or provoked left ventricular outflow tract (LVOT) gradient of ≥ 50 mmHg. The presence of haemodynamically significant obstruction in an otherwise asymptomatic patient raises specific management considerations.

Key Finding

LVOT Gradient ≥50 mmHg

A resting or provoked LVOT gradient at or above this threshold is the defining feature of this scenario, identifying a subgroup of HCM patients in whom the obstruction warrants clinical attention despite the absence of overt symptoms.

Treatment Approach (Partial)

In selected cases, pharmacological therapy targeting reduction of left ventricular pressures may be considered — a specific class of agents is involved in the initial approach.

The complete structured regimen — including agent selection, sequencing, and clinical criteria — is available in the full protocol.

Instant Access to Structured Evidence-Based Regimens

References

DOI: 10.1093/eurheartj/ehad194

Beta-blockers or verapamil may be considered in selected cases in asymptomatic patients with resting or provoked LVOTO to reduce LV pressures.

View source ↗